Research Article

New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients

Table 2

The clinical and biochemical parameters of patients according to LVMI groups.

LVMI > 130 g/m2
(: 57)
LVMI ≤ 130 g/m2
(: 102)
value

Age (years)42.2 ± 10.6 37.2 ± 10.5 0.002
Gender (M)44 (66.7%)74 (64.9%)0.871
Dialysis duration (months)47.0 ± 49.535.8 ± 46.30.165
Posttransplant duration (months)54.6 ± 52.255.4 ± 53.70.930
GFR (mL/min)63.23 ± 23.87 72.65 ± 24.01 0.012
Creatinine (mg/dL)1.4 ± 0.5 1.2 ± 0.5 0.049
Albumin (g/L)4.0 ± 0.44.1 ± 0.30.43
Hemoglobin (g/dL)13.2 ± 2.013.2 ± 1.90.845
T. Chol (mg/dL)213.9 ± 52.4209.7 ± 54.10.610
LDL Chol (mg/dL)120.0 ± 40.0117.9 ± 34.30.723
HDL Chol (mg/dL)47.6 ± 14.249.2 ± 14.00.462
Triglyceride (mg/dL)193.9 ± 88.2 164.4 ± 105.3 0.047
Calcium (mg/dL)9.4 ± 0.69.2 ± 0.60.065
Phosphorus (mg/dL)3.1 ± 0.53.2 ± 0.70.301
PTH (pcg/mL)170.8 ± 115.1157.2 ± 131.5 0.492
Glucose (mg/dL)119.1 ± 52.2 93.8 ± 22.0 0.0001
Office SBP (mmHg)143.9 ± 17.1 130.7 ± 21.9 0.0001
Office DBP (mmHg)87.9 ± 10.4 82.3 ± 14.7 0.01
HbA1c7.4 ± 1.6 6.3 ± 1.2 0.0001
BMI (kg/m2)26.9 ± 4.425.3 ± 4.90.102
Fat mass (kg)17.7 ± 8.116.2 ± 9.00.310
Fat free mass (kg)55.8 ± 12.354.5 ± 9.4 0.532
Visceral fat mass (kg)7.25 ± 3.86.42 ± 4.430.237
Muscle mass (kg)53.7 ± 9.951.8 ± 9.00.244